Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/2003
08/21/2003US20030158238 Treating diseases such as cancer, inflammatory disorders, restenosis,
08/21/2003US20030158225 Novel compounds
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders
08/21/2003US20030158201 Method for treating septic shock
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158192 Activating cytokine biosynthesis, viricides treating a viral disease, antitumor agents, immunomodulators
08/21/2003US20030158189 Non-steroidal antiinflammatory agents treating bone disorders, Crohn's disease, and inflammatory bowel disease, respiratory disorders such as chronic obstructive pulmonary disease, infections, autoimmune diseases
08/21/2003US20030158133 Use of such inhibitors or activators in treatment of dilated cardiomyopathy, pulmonary hypertension and/or other medical conditions related to PDE3 effects on cAMP levels in different intracellular compartments
08/21/2003US20030158122 For treatment of hyperlipidemia and blood coagulation disorders and to reduce levels of virus, bacteria, and endotoxins in blood stream
08/21/2003US20030158121 Novel $G(y)crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same
08/21/2003US20030158120 Combination product comprising melagatran and a factor xa inhibitor
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158096 Novel molecule
08/21/2003US20030157582 Endogenous coagulation activator compounds - use in exploring endogenous coagulation
08/21/2003US20030157516 Medical diagnosis; binding with adenine
08/21/2003US20030157474 Removal antigens from blood
08/21/2003US20030157225 Food product and process
08/21/2003US20030157142 Implants with a phosphazene-containing coating
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157078 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell
08/21/2003US20030157077 Induction of chimera mixture; anticancer agents, leukemia
08/21/2003US20030157030 Methods and compositions for therapeutic use of rna interference
08/21/2003CA2476454A1 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476162A1 Jnk inhibitor
08/21/2003CA2476027A1 Alpha-substituted arylalkyl phosphonate derivatives
08/21/2003CA2476017A1 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
08/21/2003CA2475882A1 Alpha-substituted heteroarylalkyl phosphonate derivatives
08/21/2003CA2475770A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn.gamma.g(g)
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003CA2475522A1 Method of radio-labelling biomolecules
08/21/2003CA2474195A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003CA2472822A1 Chemical compounds
08/20/2003EP1336620A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
08/20/2003EP1336605A1 Substituted benzene derivatives or salts thereof
08/20/2003EP1335939A1 Nitroderivatives of polysaccharides
08/20/2003EP1335938A2 Apolipoprotein analogues
08/20/2003EP1335932A1 Isolation of lectins
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335919A1 Novel compounds
08/20/2003EP1335918A1 Novel compounds
08/20/2003EP1335746A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003CN1437608A O-aryl glucoside SGL T2 inhibitors and method
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1436571A Thrombosis resisting composition
08/20/2003CN1118572C G-CSF analogue compisition, and preparing process thereof
08/20/2003CN1118571C Active protein with thrombopoietin
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/20/2003CN1118291C Tea for treating human body blood diseases
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/19/2003CA2070254C Thrombin inhibitors
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066859A2 Amino acid sequences capable of facilitating penetration across a biological barrier
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066824A2 Albumin-fused kunitz domain peptides
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066650A2 Short interfering rna molecules directed towards a tissue factor coding nucleic acid
08/14/2003WO2003066637A1 Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders
08/14/2003WO2003066599A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066588A1 Water soluble phenylglycine derivatives
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003WO2003065997A2 Anti-infarction molecules
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003029433A3 Chimeric viral vectors for gene therapy
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003WO2003004019A8 Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153610 Substituted oxazolidinones and their in the field of blood coagulation
08/14/2003US20030153604 Anticoagulants
1 ... 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 ... 671